Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NET”

430 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 430 results

Early research (Phase 1)Looking for participantsNCT06479811
What this trial is testing

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Who this might be right for
Head and Neck TumorsKidney CancersSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI) 120
Not applicableUnknownNCT05909319
What this trial is testing

Identification and Verification of Neutrophil Extracellular Trap Net Related Markers in Acute-on-chronic Liver Failure

Who this might be right for
Acute-On-Chronic Liver Failure
First Affiliated Hospital of Wenzhou Medical University 200
Not applicableEnrolling By InvitationNCT05746767
What this trial is testing

Supporting Peer Interactions to Expand Access to Digital Cognitive Behavioral Therapy for Spanish-speaking Patients

Who this might be right for
Depression, Anxiety
University of California, Irvine 426
Not applicableStudy completedNCT04840212
What this trial is testing

The Effectiveness of Aromatherapy in an Urban, Safety-Net Hospital on Pain

Who this might be right for
Pain Management
Parkland Health and Hospital System 184
Testing effectiveness (Phase 2)Ended earlyNCT05420636
What this trial is testing

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

Who this might be right for
Small-cell Lung CancerNeuroendocrine Carcinoma
Fox Chase Cancer Center 20
Not applicableLooking for participantsNCT05906316
What this trial is testing

A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study

Who this might be right for
Mycobacterium Avium Complex Pulmonary Disease
Radboud University Medical Center 100
Not applicableUnknownNCT05577104
What this trial is testing

Wound Bed Preparation for Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot
Nanjing First Hospital, Nanjing Medical University 40
Testing effectiveness (Phase 2)Ended earlyNCT03246906
What this trial is testing

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+14 more
Fred Hutchinson Cancer Center 150
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Not applicableStudy completedNCT05246319
What this trial is testing

Preoperative Imaging in Patients With Small Bowel Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsSmall Intestinal NETLymph Node Metastasis
Laurent BRUNAUD 50
Not applicableUnknownNCT01763554
What this trial is testing

Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014

Who this might be right for
Neuroendocrine Tumors, NET
AHS Cancer Control Alberta 115
Not applicableLooking for participantsNCT07498231
What this trial is testing

COronoary Microcirculation Analysis NETwork

Who this might be right for
Coronary Artery DiseaseMicrocirculation ResistanceMicrocirculation; Biomarkers; Myocardial Ischemia+4 more
Medical University of Bialystok 180
Very early researchLooking for participantsNCT06888102
What this trial is testing

A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer

Who this might be right for
High-risk Prostate Cancer
Edwin Posadas, MD 20
Not applicableActive Not RecruitingNCT06577220
What this trial is testing

Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement

Who this might be right for
Cervical CancerHuman Papillomavirus Infection
Baylor College of Medicine 111
Not applicableStudy completedNCT04297228
What this trial is testing

Pediatric Obesity Treatment in a Safety Net Clinic: Piloting the Step by Step Program

Who this might be right for
Pediatric ObesityOverweight and Obesity
Community Volunteers In Medicine 16
Not applicableStudy completedNCT02989987
What this trial is testing

NET for SGBV Survivors in Eastern DR Congo

Who this might be right for
Posttraumatic Stress DisorderShame
University of Konstanz 201
Not applicableStudy completedNCT04801784
What this trial is testing

Fluid Balance Neutralization During CRRT (Continuous Renal Replacement Therapy)

Who this might be right for
Fluid Overload
Hospices Civils de Lyon 65
Not applicableStudy completedNCT05012501
What this trial is testing

Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients

Who this might be right for
Neutrophil Extracellular Trap FormationPortal Vein ThrombosisLiver Cirrhosis
The Affiliated Hospital of Qingdao University 79
Not applicableLooking for participantsNCT06356467
What this trial is testing

Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs

Who this might be right for
Neuroendocrine TumorsGEP-NET
IRCCS San Raffaele 450
Testing effectiveness (Phase 2)Study completedNCT03352934
What this trial is testing

Avelumab Treatment in Patients With Neuroendocrine Carcinomas (NEC G3) Progressive After Chemotherapy

Who this might be right for
Cancer
Johannes Gutenberg University Mainz 60
Load More Results